YAP1 and non-small cell lung carcinoma: Based on the findings in this study, we for the first time suggest that miR-138 inhibits the growth and metastasis of NSCLC cells partly at least via targeting YAP1, suggesting that the miR-138/YAP1 axis may serve as a potential target for the treatment of NSCLC.